{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-145983","form_type":"8-K","ticker":"MREO","cik":"0001719714","company_name":"Mereo BioPharma Group plc","filed_at":"2024-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.727755+00:00","generated_at":"2026-06-01T09:15:39.931059+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"All seven proposals approved at Mereo BioPharma 2024 AGM; director re-elections pass with >91% support","bullets":["Annual report adopted with 99.66% of votes cast in favor; PwC reappointed as auditor (99.60% support).","Dr. Denise Scots-Knight re-elected as director (91.13% for), Dr. Jeremy Bender re-elected (92.46% for), Dr. Anders Ekblom re-elected (94.12% for).","Directors' remuneration report approved with 98.63% of votes cast in favor.","All votes based on 536,018,312 ordinary shares represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-145983","json":"https://secwatch.observer/filing/0001193125-24-145983.json","markdown":"https://secwatch.observer/filing/0001193125-24-145983.md","text":"https://secwatch.observer/filing/0001193125-24-145983.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719714/000119312524145983/0001193125-24-145983-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719714/000119312524145983/d840193d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T09:15:39.931059+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}